Arca
Skip to content
Tools
Tools

Coronavirus infection

Drug research and approvals for coronavirus infection: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 21, 2026, 279 studies of coronavirus infection are recruiting on ClinicalTrials.gov, and Health Canada has authorized 0 drug trials for it since 2013.

  • Recruiting worldwide: 279
  • Trials authorized in Canada: 0
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting now

Newest posted first, of 279 recruiting on ClinicalTrials.gov ↗

How its trials ended

871 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 221 whose ending is known, 21% met their primary endpoint, 18% missed it and 61% stopped early.

  • Completed, result not reported34840%
  • Status unknown22526%
  • Stopped: other or unclear809%
  • Ongoing779%
  • Met its primary endpoint465%
  • Missed its primary endpoint405%
  • Stopped: enrollment or feasibility314%
  • Stopped: sponsor or business decision101%
  • Stopped: lack of efficacy91%
  • Stopped: safety3<1%
  • Stopped: funding2<1%

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.